Kennedy Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Buy
38,067
+1,085
+3% +$48.5K 0.03% 469
2026
Q1
$1.78M Buy
36,982
+3,024
+9% +$141K 0.04% 433
2025
Q4
$1.65M Buy
33,958
+9,951
+41% +$493K 0.03% 442
2025
Q3
$1.13M Buy
24,007
+11,252
+88% +$543K 0.03% 495
2025
Q2
$616K Buy
+12,755
New +$652K 0.01% 538

Other funds holding SNY

Kennedy Capital Management's SNY Position: Q2 2026 in Review

Kennedy Capital Management increased its Sanofi (SNY) stake by 2.9% in Q2 2026, buying an estimated $48.5K and bringing the position to 38,067 shares worth $1.62M. The position accounts for 0.03% of the portfolio, ranked #469.

Kennedy Capital Management first reported a position in SNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.78M in Q1 2026. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Kennedy Capital Management held 38,067 shares of Sanofi worth $1.62M as of Q2 2026.
  • Kennedy Capital Management bought 1,085 Sanofi shares in Q2 2026, an estimated $48.5K.
  • Sanofi made up 0.03% of Kennedy Capital Management's portfolio in Q2 2026, its #469 holding.
  • Kennedy Capital Management first reported a position in Sanofi in Q2 2025 and has held it in 5 quarters since.
  • Kennedy Capital Management's Sanofi position peaked at $1.78M in Q1 2026.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.